Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene

doi:10.21203/rs.3.rs-4196770/v1

Download PDF

Article

Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene

https://doi.org/10.21203/rs.3.rs-4196770/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 10 Aug, 2024

Read the published version in Scientific Reports →

You are reading this latest preprint version

Sequence variants in Eyes Shut Homolog (EYS) gene are one of the most frequent causes of autosomal recessive retinitis pigmentosa (RP). Herein, we describe an Italian RP family characterized by EYS-related pseudodominant inheritance. The female proband, her brother, and both her sons showed typical RP, with diminished or non-recordable full-field electroretinogram, narrowing of visual field, and variable losses of central vision. To investigate this apparently autosomal dominant pedigree, next generation sequencing (NGS) of a custom panel of RP-related genes was performed, further enhanced by bioinformatic detection of copy-number variations (CNVs). Unexpectedly, all patients had a compound heterozygosity involving two known pathogenic EYS variants i.e., the exon 33 frameshift mutation c.6714delT and the exon 29 deletion c.(5927þ1_5928-1)_(6078þ1_6079-1)del, with the exception of the youngest son who was homozygous for the above-detailed frameshift mutation. No pathologic eye conditions were instead observed in the proband’s husband, who was a heterozygous healthy carrier of the same c.6714delT variant in exon 33 of EYS gene. These findings provide evidence that pseudodominant pattern of inheritance can hide an autosomal recessive RP partially or totally due to CNVs, recommending CNVs study in those pedigrees which remain genetically unsolved after the completion of NGS or whole exome sequencing analysis.

Biological sciences/Genetics

Health sciences/Health care

Health sciences/Molecular medicine

Health sciences/Diseases/Eye diseases/Hereditary eye disease

inherited retinal dystrophy

autosomal recessive retinitis pigmentosa

EYS gene variant

pseudodominant inheritance

genetic testing

copy-number variation

Retinitis pigmentosa (RP, OMIM #268000) is a collective term used to describe a heterogeneous group of inherited retinal dystrophies (IRDs) characterized by photoreceptors death with a progressive loss of visual functions. RP is the most frequent form of monogenic IRD affecting around 1 in 4,000 individuals. Age of onset is variable, with symptoms that can develop from childhood to adulthood. [1, 2] RP is typically labeled as rod-cone IRD, being primarily associated with rods damage with consequent nyctalopia and visual field constriction, followed by a detrimental by-stander effect on cones and their central vision functions. RP is associated to high genotypic heterogeneity, and it can segregate as an autosomal dominant, autosomal recessive, or X-linked recessive trait. [3–5] Furthermore, several RP cases with mitochondrial inheritance, digenic mutations and/or pseudodominant transmission have been hitherto reported. [6–12] In the last years, pseudodominant pedigrees have been uncovered mainly assessing the female symptomatic carriers of X-linked RP, [8–10] and, to lesser extent, families with autosomal recessive RP (arRP) [11–13] despite this is the most prevalent form of IRD worldwide. [4, 5] In particular, the Eyes Shut Homolog (EYS) is the largest gene expressed in the human retina spanning over 2000 bp within the RP25 locus (6q12.1-6q15), and its sequence variants are extremely frequent causes of arRP. [4, 14–19] EYS was discovered to be an orthologue of a Drosophila melanogaster gene coding for an extracellular protein involved in the formation of the inter-rhabdomeral space by interacting with the transmembrane glycoprotein prominin, a function that appears to be conserved in human retina and altered when damages to photoreceptors are observed. In humans, immunohistochemical findings revealed the localization of the protein in the outer segment of photoreceptors layer adjacent to the retinal pigment epithelium (RPE). [20–22] Four protein isoforms exist, whose functions are not still fully understood. However, sub-cellular evidence indicate that the EYS protein may play a key role during retinal morphogenesis and, subsequently, for the structural stability of the ciliary axoneme in both rod and cone photoreceptors, also allowing ciliary transport. [23, 24] To the best of our knowledge, this is the first reported family with pseudodominant RP due to EYS mutations that included a copy-number variation (CNV) not directly detectable by genomic sequencing technologies such as next generation sequencing (NGS) and whole exome sequencing (WES).

The reportedly non-consanguineous RP family of this study included six individuals in a two-generation pedigree originating from the North-East of Italy (Fig. 1).

Figure 1.

All family members were clinically and genetically investigated, including the female proband who was referred for RP (I:2), three affected relatives (I:3 the proband’s brother, II:2 and II:3 the proband’s sons), and two unaffected individuals i.e., the proband’s husband (I:1) and the wife of the eldest proband’s son (II:1). The parents of the proband and of her husband were deceased. In particular, the familial anamnesis did not reveal any specific history of RP/IRD in earlier generations, even though complete information was not available, especially regarding the proband’s father who died when he was just 46 years old without ever undergoing any ophthalmologic visit. Starting from the second or third decade of life, all patients with RP in the family experienced night blindness, followed by the bilateral diagnosis of progressive visual field constriction using standard automated perimetry (SAP). The last ophthalmic examinations of each family member were accomplished in September 2023. The findings collected during these visits are detailed in Table 1, together with anamnestic and genotypic data.

Table 1. Summary of demographic, anamnestic, clinical and genotypic findings.

ID / Sex /Age	Initial Symptom / Age at Onset (yo)	Refraction (ESD) OD / OS	BCVA (SE) OD / OS	SAP Visual Field MD (dB) OD / OS	IOP (mmHg) OD / OS	LOCS III (NO-NC-C-P) OD / OS	CRT (SD-OCT) OD / OS	ff-ERG Amplitude (mVolts) OD / OS	*EYS* Genotype-Phenotype Correlation	*First Report of EYS* Variants**
I:2 / F / 60 yo *	NB / 26	-1.25 / -2.00	20/80 / 20/63	-32.16 / -31.93	14 / 16	1-1-0-2 / 1-1-0-2	143 / 155	0.0 / 0.0	Het-Ex29/Het-Ex33 / RP	Ref: 20, 25
I:3 / M / 54 yo	NB / 20	-6.00 / -5.25	20/125 / HM	-31.88 / NF	16 / 10	1-1-0-2 / NF	135 / NF	0.0 / NF	Het-Ex29/Het-Ex33 / RP	Ref: 20, 25
I:1 / M / 62 yo	None / NA	+1.50 / +2.00	20/20 / 20/20	-0.71 / -0.85	18 / 18	1-1-0-0 / 1-1-0-0	251 / 254	244.6 / 245.8	Het-Ex33 / NR	Ref: 20
II:2 / M / 38 yo	NB / 30	-5.50 / -6.00	20/25 / 20/20	-22.76 / -20.37	16 / 14	0-0-0-1 / 0-0-0-1	304 / 298	112.3 / 106.8	Het-Ex29/Het-Ex33 / RP	Ref: 20, 25
II:3 / M / 35 yo	NB / 28	-2.75 / -3.25	20/20 / 20/25	-30.19 / -31.16	16 / 16	0-0-0-1 / 0-0-0-1	315 / 293	78.9 / 72.6	Hom-Ex33 / RP	Ref: 20
II:1 / F / 37 yo	None / NA	+0.50 / +0.25	20/20 / 20/20	-0.34 / -0.27	16 / 16	0-0-0-0 / 0-0-0-0	259 / 256	268.9 / 267.5	Normal / NR	NA

Abbreviations: ID, Identification code of patients; yo, year-old; F, Female; *, Proband; M, Male; NB, Night Blindness; NA, Not Applicable; ESD, Equivalent Spherical Diopters; OD, Oculus Dexter; OS, Oculus Sinister; BCVA, Best Corrected Visual Acuity; SE, Snellen Equivalent; HM, hand movements; SAP, Standard Automated Perimetry (Humphrey 30-2 visual field, SITA standard strategy, and III-white stimulus); MD, Mean Deviation; dB, Decibel; NF, Not Feasible; IOP, Intraocular Pressure; LOCS III, Lens Opacities Classification System III; NO, Nuclear Opalescence; NC, Nuclear Color; C, Cortical cataract; P, Posterior subcapsular cataract; CRT, Central Retinal Thickness; SD-OCT, Spectral-Domain Optical Coherence Tomography; ff-ERG, full-field Electroretinography; EYS, Eyes Shut Homolog gene; Het-Ex29/Het-Ex33, compound heterozygosity in EYS exon 29 [c.(5927þ1_5928-1)_(6078þ1_6079-1)del] and EYS exon 33 [c.6714delT]; RP, Retinitis Pigmentosa; Het-Ex33, single heterozygosity in EYS exon 33 [c.6714delT]; NR, Normal Retina; Hom-Ex33, homozygosity in EYS exon 33 [c.6714delT]; Ref, reference’s number in this article.

Both eyes of all individuals were fully assessed, with the exception of the left eye of the proband’s brother (I:3) which was not explorable because of a total corneal leukoma with dense white scar due to perforating ocular trauma occurred when he was 41 years old. After the most appropriate correction of the refractive errors, a marked reduction of best-corrected visual acuity (BCVA) was present only in the eyes of RP patients over 50 years of age (I:2 and I:3; Table 1). These BCVA losses appeared to be independent from the extents of the posterior subcapsular cataract, whereas their magnitudes were proportional to the severity of the central retinal atrophy diagnosed by the autofluorescence (AF) imaging of the macular area (I:2 and I:3; Fig. 2A). In both eyes of patients in the fourth decade of life, AF imaging revealed the typical, RP-related, hyper-autofluorescent perifoveal rings (II:2 and II:3; Fig. 2A), whose larger diameters were consistent with the unexpected findings of less aggressive retinopathy in the oldest brother, characterized by more preserved visual fields in comparison with the youngest one (II:2 vs. II:3; Fig.3).

Figure 2.

Figure 3.

Ophthalmoscopic fundus examination of all RP patients showed variable amounts of vitreous degeneration, optic disc pallor, attenuated retinal vessels, and degenerative changes of the retinal pigment epithelium with mid-peripheral bone spicule-shaped pigment deposits. As well, the tracings of full-field electroretinography (ff-ERG) were extinguished or significantly reduced (Table 1). Spectral-domain optical coherence tomography (SD-OCT) detailed moderate-to-severe macular degenerative changes, variably involving the vitreomacular interface, inner and outer retinal layers, and RPE (Fig. 2B). None of the RP patients showed additional disorders suggestive of either Usher’s syndrome or other syndromic RPs. Finally, complete ophthalmologic examination, SAP, SD-OCT, and ff-ERG were also conducted on asymptomatic family members (I:1 and II:1), without showing any significant ocular disorder (Table 1). Phenotypically, the family pedigree was therefore characterized by an apparent autosomal dominant RP inheritance, with affected male and female individuals belonging to two contiguous generations - see the blue elements inserted in Fig. 1. However, genotypic assessment by means of NGS enhanced by bioinformatic analysis for the detection of copy-number variations (CNVs), followed by validation with Multiplex Dependent Probe Amplification (MLPA) assay, allowed the unexpected identification of two known pathogenic RP variants in different exons of the EYS gene (RefSeq NM_001142800.2): i. the frameshift variant c.6714delT p.(Ile2239Serfs*17) in exon 33; [11,15,20] ii. the recurrent deletion c.(5927þ1_5928-1)_(6078þ1_6079-1) of exon 29. [25,26] (Fig. 4)

Figure 4.

Particularly, in patients I:2, I:3, and II:3, both pathogenic variants were identified in compound heterozygosity, whereas patient II:2 was homozygous for c.6714delT. In this pseudodominant pedigree, the molecular characterization of both EYS alleles in the proband’s husband (I:1) revealed the condition of heterozygous healthy carrier for the frameshift mutation c.6714delT in exon 33, whereas no significant EYS variants were observed in the wife of the eldest proband’s son (II:1) (Table 1).

IRDs represent a wide group of syndromic and non-syndromic genetic diseases. When the retina is the unique involved tissue, the most frequent phenotype is non-syndromic RP, which is primarily caused by the death of rod photoreceptor cells with consequent early degeneration of both outer retinal layers and RPE. [4,27] To date, all together considering the three Mendelian inheritance patterns (i.e., autosomal dominant, autosomal recessive, and X-linked), about one-hundred causative genes have been described in association with non-syndromic RP, being arRP the most common IRD worldwide with 70 genes so far mapped as pathogenic loci just of this monogenic vision-threatening disease. [5] In particular, EYS gene variants are very frequent causes of non-syndromic RP in autosomal recessive pedigrees of both European and Asian descents, [5] affecting about 5-7% of patients with arRP [14,18], but arriving to account for 10 to 30% of these specific IRD cases in some European countries of the Mediterranean area [15,16,19] and in Japan. [17] In this Italian family with EYS-related RP, the disease seemed to follow a dominant pattern of inheritance, as the affected individuals belonged to both sexes and contiguous generations. However, in our proband female (I:2), the NGS of a large panel of RP-related genes did not reveal any conclusive data, just identifying the single c.6714delT heterozygosity in exon 33 of EYS gene that had been exclusively reported in arRP cases. [11,15,20]

Nevertheless, suspecting a hidden pathogenic EYS genotype [16,28] further investigation in terms of bioinformatic detection of CNVs has led to the identification of a second known structural variant in the EYS gene of the proband [25,26], allowing the identification of two different pathogenic allelic combinations in the same family, i.e., compound heterozygosity and homozygosity. Both combinations result in typical RP forms with diminished or non-recordable ff-ERG due to the primary damages of the prevalent rod photoreceptors. Such model of segregation can be categorized as pseudodominant inheritance, which occurs when an individual carrying a known recessive disorder has a clinically unaffected partner, but surprisingly their children present the same recessive disease as the affected parent, thus appearing as a classic autosomal dominant inheritance (Fig. 1). The large majority of patients harboring EYS mutations are phenotypically labeled as typical RP (i.e., rod-cone IRD), in which peripheral visual field begins to progressively narrow during the second or third decade of life [14-20,22,24,25] and central retinal atrophy is especially present in older individuals. [26,29] In particular, consistent with the findings of Soares and co-workers, [26] rods degeneration with bone spicule pigmentation in all retinal quadrants appeared to be influenced by the patient’s age in our affected family members, with the individuals in the sixth decade of life characterized by more densely pigmented retinas (siblings I:2 and I:3) in comparison with the individuals in the fourth decade of life (siblings II:2 and II:3). As well, according to recently reported in both Italian and Portuguese patients with EYS-related arRP, [26,29] central retinal atrophy was clearly manifest exclusively in our older siblings, whereas in the younger ones a rather intact macular and peri-macular areas were observed (Fig. 2A). On the other hand, in contrast with the expected natural history of typical rod-cone IRD that implies an age-related worsening of the visual field, [1,4,27] in our young-adult brothers with different causative RP genotypes there is evidence of different disease’s severity at the same age. In fact, comparing their SAP exams when they were both 30 years old, very more evident deterioration of visual field were bilaterally recorded in the youngest brother (II:3) with EYS-c.6714delT homozygosity in respect to the oldest one (II:2) with compound heterozygosity of the two EYS mutant alleles (Fig. 3). Although no data in scientific literature are informative about different IRD severity between patients with homozygous versus compound heterozygous EYS genotypes, this intrafamilial comparison indicates that homozygosity causes worse and faster visual field deterioration in comparison with compound heterozygosity. Particularly, the homozygous 1-bp EYS deletion c.6714delT in exon 33 found in patient II:3 results in a frameshift which is ultimately predicted to cause premature termination p.(Ile2239Serfs*17) of the EYS protein. Such premature truncation is expected to occur within the second laminin A G-like domain; therefore, either the transcript undergoes nonsense mediated mRNA decay, or the mutant protein will be likely lacking six EGF(Epidermal Growth Factor)-like and three laminin A G-like domains. [20]

Several possibilities may be considered to explain this unusual pseudodominant pattern of inheritance, including: i. family consanguinity; ii. segregated geographic origin; iii. recurrence of the shared pathogenic variant. [12,16] In the herein described pedigree, the female RP proband and her normal husband were reportedly unrelated, but they originated from the same geographical area of the Veneto region thus implying the chance of a distant kinship. Moreover, the well-known EYS-c.6714delT frameshift mutation in exon 33 may be expected as a quite recurrent sequence variant especially in specific populations, such as that of the North-East of Italy. The present findings confirm that pseudodominant EYS-related RP may be diagnosed when this retinal rare disease is observed in two next generations of the same pedigree. [11,16] In the course of the normal clinical practice for the complex management of patients with IRDs, NGS custom panels operationally represent unbiased choice for the molecular characterization of genetically heterogeneous disorders such as RP, other than a viable compromise between diagnostic yield, time consumption, and running costs. [30-32] On the other hand, the composite diagnostic pathway reported by ours on also emphasizes the recommendations of Zampaglione and co-workers, [28] about the need of CNVs study for arriving at a tailored molecular diagnosis in a significant percentage of IRD cases erroneously labeled as “genetically unsolved” after the carrying out of NGS and/or WES. A deep genotyping attitude can be decisive to strengthen the close teamwork between ophthalmologists and geneticists, and to address the unmet patients’ needs. In an ever-closer multidisciplinary prospect of gene-based therapies and/or medically assisted reproduction procedures with preimplantation genetic diagnosis, [33-36] the expanding of our comprehension of IRDs is especially important to outline the exact genotype-phenotype correlation in each patient or family with disabling genetic rare diseases sometimes characterized by challenging patterns of inheritance.

All the participants to this study were clinically examined at the ERN-EYE Center for Retinitis Pigmentosa of the Veneto Region (Camposampiero Hospital, HCP Azienda ULSS 6 Euganea, Padova, Italy). In the affected patients, the diagnosis of typical RP (i.e., rod-cone IRD) was based on the usual disease’s symptoms (such as night blindness and loss of peripheral vision), together with pathognomonic bilateral alterations in visual field, ophthalmoscopy, and full-field electroretinography (ff-ERG). In addition, pure tone audiometry was accomplished to rule out Usher’s syndrome; other syndromic RPs were also excluded by means of the evaluation of medical data. Each family members had a complete ophthalmic examination, including anamnesis, ocular refraction, best-corrected visual acuity (BCVA) measured in decimal equivalents by standard logarithmic chart at a test distance of three meters, slit lamp biomicroscopy with lens assessment performed according to the Lens Opacities Classification System III (LOCS III), [37] tonometry, funduscopy after pupil dilatation, computerized static threshold visual field exam using the central 30-2 SITA standard strategy and III-white stimulus of the Humphrey field analyzer (HFA; Carl Zeiss, Oberkochen, Germany), macular spectral-domain optical coherence tomography (SD-OCT) using Spectralis platform (Heidelberg Engineering, Inc, Heidelberg, Germany), and ff-ERG recorded by Retimax Plus system (Costruzioni Strumenti Oftalmici, Florence, Italy) according to the standards of the International Society for Clinical Electrophysiology of Vision (ISCEV) and also considering healthy individuals as control group. [9,38]

Genomic DNA was extracted from blood samples and analysed by an NGS-targeted panel of 283 genes associated to RP/IRD. The genotyping, from the library preparation, the targeted exome sequencing using the v2 reagent kit Illumina and MiSeq platform (Illumina, San Diego, CA, USA) to the reference alignment (GRCh19), was performed following all the manufacturer’s protocol, obtaining BAM, BAI and FASTQ raw data files as well as VCF and TSV files that contain all the detected variants. All the coverage data were listed for each amplicon, and the mean coverage and coverage uniformity for each analysed gene were calculated (as suggested by Illumina TechSupport). Next generation sequencing was carried out by means of Illumina TruSeq library preparation kit and Illumina HiSeq X platform. The CNVs have been assessed by means of SureCall pair analysis and confirmed through Multiplex Dependent Probe Amplification (MLPA). For detection of CNVs in exonic sequences of the EYS gene the SALSA MLPA Probe mix P328-A1-0811 or P328-A2-0217 lacking probes for exon 9 or exons 2, 7, 9 and 27, respectively (MRC Holland, Amsterdam, Netherlands) were used. The MLPA reactions were run on ABI 3500xL Dx Genetic Analyzer (Applied Biosystems) and the data was evaluated in Gene Marker v.2.7.0 (Soft Genetics, State College, PA, USA).

Research protocols involving patients’ DNA, as well as from related individuals, were approved by the Clinical Research Ethics Committee of the HCP Azienda Ospedale Università of Padova, Padova, Italy (TREC2015-XJS07). Informed consents were obtained from all the participants or their legal guardians. All procedures followed the tenets of the Declaration of Helsinki.

Identification code of patients

year-old

Female

Proband

Male

Night Blindness

Not Applicable

ESD

Equivalent Spherical Diopters

Oculus Dexter

Oculus Sinister

BCVA

Best Corrected Visual Acuity

Snellen Equivalent

hand movements

SAP

Standard Automated Perimetry (Humphrey 30 − 2 visual field,SITA standard strategy,and III-white stimulus)

Mean Deviation

Decibel

Not Feasible

IOP

Intraocular Pressure

LOCS III

Lens Opacities Classification System III

Nuclear Opalescence

Nuclear Color

Cortical cataract

Posterior subcapsular cataract

CRT

Central Retinal Thickness

SD-OCT

Spectral-Domain Optical Coherence Tomography

ff-ERG

full-field Electroretinography

EYS

Eyes Shut Homolog gene

Het-Ex29/Het-Ex33

compound heterozygosity in EYS exon 29 [c.(5927þ1_5928-1)_(6078þ1_6079-1)del] and EYS exon 33 [c.6714delT]

Retinitis Pigmentosa

Het-Ex33

single heterozygosity in EYS exon 33 [c.6714delT]

Normal Retina

Hom-Ex33

homozygosity in EYS exon 33 [c.6714delT]

Ref

reference’s number in this article.

Acknowledgments

None

Author contributions

Conception and design: E.D.I, A.S., and F.P.

Data collection: E.D.I., G.G.A., K.D.N., M.M., F.B., and M.T.

Analysis and interpretation: E.D.I., U.S. V.B., M.P., L.S., and F.P.

Writing the manuscript: E.D.I, G.G.A, K.D.N., U.S., F.N., and F.P.

Revision of the manuscript: E.D.I, U.S., M.P., A.S., L.S., and F.P.

Overall responsibility: M.M., M.T., and L.S.

All Authors reviewed the manuscript.

Data availability

All data generated or analyzed during this clinical study are included in this article.

The datasets generated and analysed during the current study are available in the ClinVar repository and Database of Genomic Variants, i.e.:

https://www.ncbi.nlm.nih.gov/clinvar/variation/357699/
http://dgv.tcag.ca/dgv/app/variant?id=nsv603391&ref=GRCh37/hg19

All authors agree to make materials, data and associated procedures promptly available to readers. Further enquiries can be directed to the corresponding Author.

Additional information

No conflicting relationship exists for any Author relating to this article.

Competing interests

The Authors have no proprietary or commercial interest in any materials discussed in this article.

Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795–1809 (2006).
Chizzolini, M. et al. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr. Genomics 12, 260–266 (2011).
Ferrari, S. et al. Retinitis pigmentosa: genes and disease mechanisms. Curr. Genomics 12, 238–249 (2011).
Verbakel, S.K. et al. Non-syndromic retinitis pigmentosa. Prog. Retin. Eye Res. 66: 157–186 (2018).
Daiger, S.P., Sullivan, L.S., Bowne, S.J. & Rossiter, B.J.F. RetNet™ - Retinal Information Network. https://web.sph.uth.edu/RetNet/ (2024).
Yu-Wai-Man, P., Newman, N.J. Inherited eye-related disorders due to mitochondrial dysfunction. Hum. Mol. Genet. 26: R12-R20 (2017).
Okazaki, A. & Ott, J. Machine learning approaches to explore digenic inheritance. Trends Genet. 38: 1013–1018 (2022).
Churchill, J.D. et al. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 54: 1411–1416 (2013).
Parmeggiani, F. et al. Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia. Sci. Rep. 6: 39179 (2016).
De Silva, S.R. et al. The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog. Retin. Eye Res. 82: 100898 (2021).
Ge, Z. et al. NGS-based molecular diagnosis of 105 eyeGENE^® probands with retinitis pigmentosa. Sci. Rep. 5: 18287 (2015).
Habibi, I. et al. Different phenotypes in pseudodominant inherited retinal dystrophies. Front. Cell Dev. Biol. 9: 625560 (2021).
Robles Bocanegra, A., Tato, J., Molina Thurin, L.J., Izquierdo, N. & Oliver, A.L. Pseudodominant inheritance of retinitis pigmentosa due to mutations in the phosphodiesterase 6B gene: a case report. Cureus. 15: e34933 (2023).
Littink, K.W. et al. Mutations in the EYS gene account for approximately 5% of autosomal recessive retinitis pigmentosa and cause a fairly homogeneous phenotype. Ophthalmology 117: 2026–2033 (2010).
Barragán, I. et al. Mutation spectrum of EYS in Spanish patients with autosomal recessive retinitis pigmentosa. Hum. Mutat. 31: E1772-E1800 (2010).
Audo, I. et al. EYS is a major gene for rod-cone dystrophies in France. Hum. Mutat. 31: E1406-E1435 (2010).
Iwanami, M. et al. Five major sequence variants and copy number variants in the EYS gene account for one-third of Japanese patients with autosomal recessive and simplex retinitis pigmentosa. Mol. Vis. 25: 766–779 (2019).
Gao, F.J. et al. Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa. Ophthalmology 126: 1549–1556 (2019).
Marques, J.P. et al. Design, development and deployment of a web-based interoperable registry for inherited retinal dystrophies in Portugal: the IRD-PT. Orphanet J. Rare Dis. 15: 304 (2020).
Collin, R.W. et al. Identification of a 2 Mb human ortholog of Drosophila eyes shut/spacemaker that is mutated in patients with retinitis pigmentosa. Am. J. Hum. Genet. 83: 594–603 (2008).
Zelhof AC, Hardy R.W., Becker A., & Zuker C.S. Transforming the architecture of compound eyes. Nature 443: 696–699 (2016).
Abd El-Aziz, M.M. et al. EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat. Genet. 40: 1285–1287 (2008).
Alfano, G. et al. EYS is a protein associated with the ciliary axoneme in rods and cones. PLoS One 11: e0166397 (2016).
Garcia-Delgado, A.B. et al. Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy. Orphanet J. Rare Dis. 16: 222. (2021).
Khateb, S. et al. Identification of genomic deletions causing inherited retinal degenerations by coverage analysis of whole exome sequencing data. J. Med. Genet. 53: 600–607 (2016).
Soares, R.M. et al. Eyes shut homolog-associated retinal degeneration: natural history, genetic landscape, and phenotypic spectrum. Ophthalmol. Retina 7: 628–638 (2023).
McGuigan, D. B. et al. EYS mutations causing autosomal recessive retinitis pigmentosa: changes of retinal structure and function with disease progression. Genes (Basel) 8: 178 (2017).
Zampaglione, E. et al. Copy-number variation contributes 9% of pathogenicity in the inherited retinal degenerations. Genet. Med. 22: 1079–1087 (2020).
Placidi, G. et al. Retinitis pigmentosa associated with EYS gene mutations: disease severity staging and central retina atrophy. Diagnostics (Basel) 13: 850 (2023).
Stone, E.M. et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology 119: 2408–2410 (2012).
Black G.C. et al. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement. Orphanet J. Rare Dis. 16: 142. (2021).
Stephenson, K.A.J. et al. Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations. Orphanet J. Rare Dis. 5: 200. (2021).
Parmeggiani, F. X-chromosome insight for targeting gene therapy. Ophthalmol. Retina. 4: 521–522 (2020).
Botto, C. et al. Early and late stage gene therapy interventions for inherited retinal degenerations. Prog. Retin. Eye Res. 86: 100975 (2022).
Schneider, N. et al. Inherited retinal diseases: linking genes, disease-causing variants, and relevant therapeutic modalities. Prog. Retin. Eye Res. 89: 101029 (2022).
Park, J.G. et al. Reproductive ophthalmology: the intersection of inherited eye diseases and reproductive technologies. Retina 42: 2025–2030 (2022).
Chylack, L.T. et al. The lens opacities classification system III. The longitudinal study of Cataract Study Group. Arch. Ophthalmol. 111: 831–836 (1993).
Brigell, M., Bach, M., Barber, C., Kawasaki, K. & Kooijman, A. Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Calibration standard Committee of the International Society for Clinical Electrophysiology of Vision (ISCEV). Doc. Ophthalmol. 95: 1–14 (1998).

No competing interests reported.

Download PDF

Journal Publication

published 10 Aug, 2024

Read the published version in Scientific Reports →

Editorial decision: Revision requested
27 Jun, 2024
Reviews received at journal
25 Jun, 2024
Reviews received at journal
31 May, 2024
Reviewers agreed at journal
22 May, 2024
Reviewers agreed at journal
21 May, 2024
Reviewers invited by journal
28 Apr, 2024
Editor assigned by journal
26 Apr, 2024
Editor invited by journal
18 Apr, 2024
Submission checks completed at journal
18 Apr, 2024
First submitted to journal
31 Mar, 2024

You are reading this latest preprint version

Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Results

Discussion

Methods

Abbreviations

Declarations

References

Additional Declarations

Status:

Journal Publication

Version 1